Cell therapies such as CAR-T therapy require a specialized system for donor cell collection, preparation, transplantation, and post-transplant management. The Cell Therapy Center will work with and support each medical department to provide appropriate treatment to patients. In addition, when clinical trials and clinical research are conducted for regenerative medicine using stem cells, which has been attracting attention in recent years, the Center will support each medical department by managing cells and coordinating each department. Different cell therapies require specialized preparations, but by creating a platform for this and sharing know-how, it is believed that the effectiveness and safety of treatments can be improved.
What is cell therapy?
This is a treatment that uses cells from the patient or another person to treat cancer or restore lost function.
These include CAR-T therapy for leukemia, hematopoietic stem cell therapy, bone marrow stem cell therapy for spinal cord injuries, and stem cell therapy for intractable neurological diseases.
For more information about CAR-T treatment, please refer to Hematology website.
Cell Therapy Center
The center was established in November 2024 and is made up of a multidisciplinary team of medical doctors, Clinical Laboratory, pharmaceutical department, and Clinical Engineering.
Since the establishment of a quality management system is essential for the provision of human cell raw materials, we have created quality manuals and management procedures that comply with GMP/GCTP ordinances, mainly through our ISO15189-certified testing department.
- GMP (Good Manufacturing Practice)
Ministerial Ordinance on Standards for Manufacturing and Quality Control of Drugs and Quasi-drugs - GCTP(Good Gene, Cellular, and Tissue-Based Products Manufacturing Practice)
Ministerial Ordinance on Standards for Manufacturing and Quality Control of Regenerative Medicine Products
1. Organization and Personnel System Development: Clarification of responsibilities, deployment of specialized personnel,
thorough staff training.
2. Documentation and Record Management: Documentation of procedures, accurate creation and storage of records,
construction of a management system.
3. Continuous improvement through the PDCA cycle: Identifying and analyzing issues and areas for improvement,
implementing and verifying improvement measures, and using standardization to prevent
recurrence.
4. Traceability: Using a system to accurately manage the chain of identity (COI) for cells collected from a patient, processed into a product, and returned to the same patient.
Compliance with related laws, regulations and guidelines.
Through these efforts, we are able to ensure the quality of our human cell raw materials and provide safe and reliable products.
Organization chart
staff
| Full name | Academic societies, professional qualifications, etc. | |
| Director | Morizane Asuka | Affiliated Societies The Japan Neurosurgical Society Japan Neurosurgery Congress The Japanese Society for Neuroendovascular Therapy The Japanese Society for Regenerative Medicine International Society for Stem Cell Research Specialist Qualifications Board Certified Surgeon in Neurosurgery Cerebral Endovascular Therapy Specialist Degree Doctor of Medicine, Kyoto University Graduate School of Medicine |
| General Manager |
Tadakazu Kondo | Academic Societies The Japanese Society of Internal Medicine Japan Hematology Academic Societies Japanese Society for Transplantation and Cellular Therapy American Society of Hematology Specialist Qualifications Fellow of the Japanese Society of Internal Medicine (FJSIM) Board Certified Member of the Japanese Society of Hematology degree Kyoto University Graduate School of Medicine Doctor of Medicine |
| Quality Control Department Manager | Noboru Kometani | Affiliated Academic Societies The Japanese Society of Internal Medicine The Japanese Society of Hematology Japanese Society for Transplantation and Cellular Therapy The Japan Society of Transfusion Medicine and Cell Therapy Specialist qualification Fellow of the Japanese Society of Internal Medicine (FJSIM) Board Certified Member of the Japanese Society of Hematology |
| Head of Apheresis Department | Yuya Nagai | Affiliated Academic Societies The Japanese Society of Internal Medicine The Japanese Society of Hematology American Society of Hematology Specialist qualification Fellow of the Japanese Society of Internal Medicine (FJSIM) Board Certified Member of the Japanese Society of Hematology degree Doctor of Medicine, Kyoto University University Graduate School of Medicine |
| Head of Cell Preparation and Storage Department | Nobuhiro Hiramoto | Affiliated Academic Societies The Japanese Society of Internal Medicine The Japanese Society of Hematology Japanese Society for Transplantation and Cellular Therapy Japanese Society of Medical Oncology Professional Qualifications Board Certified Member of the Japanese Society of Internal Medicine Board Certified Member of the Japanese Society of Hematology |
| Assistant Director of Apheresis | Ryusuke Yamamoto | Affiliated Academic Societies The Japanese Society of Hematology The Japanese Society of Internal Medicine Specialist qualification Fellow of the Japanese Society of Internal Medicine (FJSIM) Board Certified Member of the Japanese Society of Hematology degree Doctor of Medicine, Kyoto University University Graduate School of Medicine |
Clinical laboratory technician, clinical engineer, pharmacist
Treatment List
Insurance medical treatment
CAR therapy (Kymriah)clinical trial
Click here for Clinical Research and InnovationFor companies and academia
Business Contents
Coordination with each medical department and division regarding the implementation of clinical trials and treatments at the hospital
- Coordination with companies and external medical institutions, and consultation service
- Cell preparation and storage management for cell therapy
- Support for follow-up of intervention patients Collaboration with the Clinical Promotion Research Center
*Our hospital does not manufacture cell preparations.
General public
Those who wish to undergo cell therapy
Our center does not provide consultations regarding individual illnesses.
Cell therapy and regenerative medicine are not applicable to all diseases.
The relative merits of these treatments compared to current general treatments vary depending on the type, symptoms, and progression of the disease. Please consult your doctor regarding your individual illness.
